[Total body irradiation and bone marrow transplant]

Area of Science:

• Oncology
• Hematology
• Radiation Biology

Background:

• Malignancies, particularly hematological ones, show sensitivity to high-dose chemotherapy and radiotherapy.
• Normal marrow toxicity limits antineoplastic agent dosage.
• Marrow transplantation enables supralethal chemoradiotherapy doses for increased cancer cell kill.

Purpose of the Study:

• To investigate the efficacy of high-dose chemoradiotherapy followed by marrow transplantation for treating malignancies.
• To explore the role of Total Body Irradiation (TBI) in eradicating malignant cells and preventing allogeneic marrow rejection.
• To assess the antitumor effect of transplanted allogeneic marrow.

Main Methods:

• Survey of radiobiological studies.
• Administration of supralethal doses of chemoradiotherapy.
• Total Body Irradiation (TBI) for tumor eradication and immune suppression.
• Allogeneic, syngenic, or autologous marrow transplantation.
• Evaluation of preliminary patient treatment results at ISSR.

Main Results:

• High-dose chemoradiotherapy can achieve complete remission in sensitive malignancies.
• TBI effectively eradicates malignant cells and suppresses host immune reactivity.
• Transplanted allogeneic marrow demonstrates an antitumor effect.
• Preliminary patient data from ISSR treatment protocols are presented.

Conclusions:

• Marrow transplantation is crucial for enabling dose escalation in cancer therapy.
• Total Body Irradiation plays a dual role in cancer treatment and transplant success.
• The combination of high-dose therapy and marrow transplantation offers a promising strategy for managing hematological malignancies.